盘龙药业 (002864)
SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 10628.10
- Circulating A-Shares(W): 7419.07
- Earnings Per Share(RMB): 0.8500
- Net Assets Per Share(RMB): 15.8444
- Operating Revenue(W RMB): 84145.24
- Total Profit(W RMB): 10670.92
- Net Profit Attributable to Parent(W RMB): 8980.59
- Net Profit Growth Rate(%): 0.26
- Weighted Return on Equity(%): 5.3900
- Operating Cash Flow Per Share(RMB): 0.8390
- Undistributed Profit Per Share(RMB): 6.6592
- Capital Reserve Per Share(RMB): 7.6918
2. Main Business
The main business covers:
- Standardized cultivation of medicinal materials
- Drug production
- Drug research and development
- Drug sales and pharmaceutical logistics
3. Company Basic Information
- Company Name: Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd.
- Listing Date: 2017-11-16
- Industry: Pharmaceutical Manufacturing
- Address: No. 2801, Baliu 2nd Road, Baqiao District, Xi'an City, Shaanxi Province
- Website: www.pljt.com
- Company Profile：The issuer is a joint stock company established through the overall change of Shaanxi Panlong Pharmaceutical Group Co., Ltd. The predecessor of the joint stock company, Panlong Pharmaceutical, was established on September 22, 1997. On May 21, 2013, the shareholders' meeting of Panlong Pharmaceutical passed a resolution to agree to change it into a joint stock company. The benchmark date for this change was December 31, 2012. Based on the audited net assets of 184,436,330.65 yuan confirmed by Lixin Certified Public Accountants, it was converted into 65,000,000 shares at a ratio of 1:0.352425, with a par value of 1 yuan per share. The net assets exceeding the share capital, amounting to 119,436,330.65 yuan, were included in the capital reserve. On June 10, 2013, Lixin Certified Public Accountants verified the above capital contribution and issued the "Xin Hui Shi Bao Zi [2013] No. 610273" "Capital Verification Report". On June 21, 2013, the issuer completed the industrial and commercial registration for the overall change at the Shaanxi Provincial Administration for Industry and Commerce and obtained the business license with the registration number 610000100202319.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Changxin Jinli Trend Hybrid Securities Investment Fund A Class | Fund | 110.00 | 1.48 |
| 2 | Shenzhen Times Bole Venture Capital Management Co., Ltd. - Jiangxi Ganjiang New District Caitou Times Bole Qichen Equity Investment Center (Limited Partnership) | Asset Management Plan | 83.62 | 1.13 |
| 3 | Rongtong Health Industry Flexible Allocation Hybrid Securities Investment Fund A Class | Fund | 60.00 | 0.81 |
| 4 | Shenzhen Times Bole Venture Capital Management Co., Ltd. - Times Bole Private Placement No. 10 Private Equity Investment Fund | General Legal Person | 52.65 | 0.71 |
| 5 | Gongqingcheng Shengheng Investment Management Co., Ltd. - Shengheng Mingjiang Jiuchong Fengkong Strategy No. 2 Private Equity Investment Fund | General Legal Person | 52.06 | 0.70 |
| 6 | ChinaAMC CSI Traditional Chinese Medicine ETF | Fund | 46.49 | 0.63 |
| 7 | Hainan Mozhu Private Fund Management Co., Ltd. - Mozhu Sleeping Beauty No. 3 Private Securities Investment Fund | Private Securities Investment Fund | 45.80 | 0.62 |
| 8 | China National Petroleum Corporation Enterprise Annuity Plan - Industrial and Commercial Bank of China Limited | Annuity | 44.77 | 0.60 |
5. Concept Sectors
- Hepatitis Concept
- Innovative Drugs
- High-Performance Stocks
- Small-Cap Non-Marginable Stocks
- Micro-Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information